We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immunity Proteins Linked to Cancer

By LabMedica International staff writers
Posted on 31 Jul 2013
Print article
Image: Crystallography of Apolipoprotein B messenger RNA-editing enzyme (Image courtesy of Justin Steinfeld).
Image: Crystallography of Apolipoprotein B messenger RNA-editing enzyme (Image courtesy of Justin Steinfeld).
A set of proteins involved in immunity, which are supposed to defend the body, have the adverse effect of creating a large number of mutations in DNA.

These genetic mutations produce tumors in the human body, especially when these proteins transform, and can account for the majority of variations in some very aggressive cancers.

Scientists from the US National Institute of Environmental Health Sciences (Durham, NC, USA) examined 954,247 mutations within 2,680 cancer samples. Almost 70% of mutations resulted from the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like cytidine deaminases (APOBEC) protein in some tumors. The investigators found that APOBEC mutations can outnumber all other mutations in some cancers, accounting for over two-thirds in some bladder, cervical, breast, head and neck, and lung tumors.

The APOBEC proteins are known to be of benefit, shutting down viruses that attack the body, but the scientists were surprised to find that they are also a detriment, mutating DNA. They found 498 total clusters in the 2,680 sequenced exomes from 14 different cancer types. In total, 218 cytosine- or guanine-coordinated clusters were identified, occurring in every cancer type analyzed except acute myeloid leukemia. Several cancer types showed high levels of the APOBEC mutation pattern as well as a wide variation among individual samples, which could reflect different biological pathways leading to carcinogenesis and the greatest range of variation was observed in breast cancer.

Dmitry A. Gordenin, PhD, a senior scientist and corresponding author of the study said, “The presence of APOBEC clusters in the genome of tumor cells indicates that APOBEC enzymes could also have caused many mutations across the genome.” His coauthor, Steven A. Roberts, added, “We hope that determining the environmental link to these mutations will lead to viable cancer prevention strategies.” The study was published on July 14, 2013, in the journal Nature Genetics.

Related Links:

US National Institute of Environmental Health Sciences


Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Tabletop Centrifuge
Mikro 185
New
Rocking Shaker
HumaRock

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.